Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction

This study has been completed.
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Titan Pharmaceuticals Identifier:
First received: April 27, 2010
Last updated: October 6, 2014
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: October 23, 2012